CareDx Promotes Living Donor Transplantation Through Employee Policy
June 05 2018 - 8:00AM
CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company
focused on the discovery, development and commercialization of
clinically differentiated, high-value diagnostic solutions for
transplant patients, announces a progressive Living Donor Employee
Recovery Policy to support employees who donate an organ or bone
marrow.
As part of the company’s commitment to the organ transplant
community, CareDx will adopt a corporate policy to support
employees who donate an organ or bone marrow to help save someone's
life. The Living Donor Employee Recovery Policy was announced at
the American Transplant Congress in Seattle, Washington alongside a
presentation on the importance of living organ donation from Kevin
Longino, CEO of the National Kidney Foundation.
“CareDx’s forward-thinking policy is an important step towards
removing some of the barriers that living donors face such as paid
time-off for donation and recovery and job security. Living organ
donors are heroes and should be treated as such. We applaud
CareDx for moving forward with an initiative that recognizes the
importance of living organ donation and we strongly encourage other
corporations to adopt similar policies,” said Longino, who is also
a kidney transplant recipient.
“Since we started with this initiative, we have received
endorsements or strong support from many organizations, including:
The National Kidney Foundation, American Association of Kidney
Patients, American Society of Transplantation, and American Society
of Transplant Surgeons. Also we have seen many individuals showing
their support. Besides being the right thing to do, the policy
highlights our overall commitment to the field of transplantation,”
says Peter Maag, CEO & President of CareDx.
About CareDx CareDx,
Inc., headquartered in Brisbane, California, is a molecular
diagnostics company focused on the discovery, development and
commercialization of clinically differentiated, high-value
diagnostic solutions for transplant recipients. CareDx offers
products along the pre- and post-transplant testing continuum.
For more information, please visit: www.CareDx.com.
CONTACTS:
CareDx, Inc.Sasha KingChief Commercial Officer+1
415-287-2393sking@caredx.com
Investor RelationsDavid ClairIntegrated Corporate Relations,
Inc.+1 646-277-1266david.clair@icrinc.com
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Aug 2024 to Sep 2024
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Sep 2023 to Sep 2024